Search Results

There are 11570 results for: content related to: Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified

  1. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

    Addiction

    Volume 105, Issue 4, April 2010, Pages: 709–718, Sandra D. Comer, Maria A. Sullivan, Suzanne K. Vosburg, Jeanne Manubay, Leslie Amass, Ziva D. Cooper, Phillip Saccone and Herbert D. Kleber

    Version of Record online : 10 MAR 2010, DOI: 10.1111/j.1360-0443.2009.02843.x

    Corrected by:

    Erratum

    Vol. 105, Issue 7, 1322, Version of Record online: 8 JUN 2010

  2. Buprenorphine

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Donald G. Barceloux, Pages: 514–526, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch28

  3. Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose-Escalation Trials

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 179–192, Dr Domenic A. Ciraulo, Dr Robert J. Hitzemann, Dr Eugene Somoza, Dr Clifford M. Knapp, Dr John Rotrosen, Dr Ofra Sarid-Segal, Ms Ann Marie Ciraulo, Dr David J. Greenblatt and Dr C. Nora Chiang

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005284192

  4. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

    The Milbank Quarterly

    Volume 93, Issue 3, September 2015, Pages: 561–583, BRADLEY D. STEIN, ROSALIE LICCARDO PACULA, ADAM J. GORDON, RACHEL M. BURNS, DOUGLAS L. LESLIE, MARK J. SORBERO, SEBASTIAN BAUHOFF, TODD W. MANDELL and ANDREW W. DICK

    Version of Record online : 8 SEP 2015, DOI: 10.1111/1468-0009.12137

  5. You have free access to this content
    Buprenorphine: An Analgesic with an Expanding Role in the Treatment of Opioid Addiction

    CNS Drug Reviews

    Volume 8, Issue 4, December 2002, Pages: 377–390, Susan E. Robinson

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2002.tb00235.x

  6. Pharmacokinetics of morphine and its surrogates X: Analyses and pharmacokinetics of buprenorphine in dogs

    Biopharmaceutics & Drug Disposition

    Volume 11, Issue 4, May/June 1990, Pages: 311–350, Edward R. Garrett and V. Ravi Chandran

    Version of Record online : 11 JAN 2006, DOI: 10.1002/bdd.2510110403

  7. Buprenorphine-Based Regimens and Methadone for the Medical Management of Opioid Dependence: Selecting the Appropriate Drug for Treatment

    The American Journal on Addictions

    Volume 19, Issue 6, November-December 2010, Pages: 557–568, Icro Maremmani and Gilberto Gerra

    Version of Record online : 21 SEP 2010, DOI: 10.1111/j.1521-0391.2010.00086.x

  8. You have free access to this content
    Post-marketing Surveillance of Methadone and Buprenorphine in the United States

    Pain Medicine

    Volume 11, Issue 7, July 2010, Pages: 1078–1091, Nabarun Dasgupta, Elise J. Bailey, Theodore Cicero, James Inciardi, Mark Parrino, Andrew Rosenblum and Richard C. Dart

    Version of Record online : 8 JUN 2010, DOI: 10.1111/j.1526-4637.2010.00877.x

  9. Buprenorphine in Maintenance Treatment: Experience among Italian Physicians in Drug Addiction Centers

    The American Journal on Addictions

    Volume 19, Issue 3, May-June 2010, Pages: 222–230, Gianluca Quaglio, Cristian Pattaro, Gilberto Gerra, Paolo Mezzelani, Linda Montanari, Don C. Des Jarlais and Fabio Lugoboni

    Version of Record online : 2 APR 2010, DOI: 10.1111/j.1521-0391.2010.00040.x

  10. Correlations of Maternal Buprenorphine Dose, Buprenorphine, and Metabolite Concentrations in Meconium With Neonatal Outcomes

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 5, November 2008, Pages: 604–612, SL Kacinko, HE Jones, RE Johnson, RE Choo and MA Huestis

    Version of Record online : 13 AUG 2008, DOI: 10.1038/clpt.2008.156

  11. Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses

    Veterinary Anaesthesia and Analgesia

    Volume 42, Issue 1, January 2015, Pages: 17–29, Emma J Love, Ludovic Pelligand, Polly M Taylor, Joanna C Murrell and John W Sear

    Version of Record online : 16 APR 2014, DOI: 10.1111/vaa.12165

  12. You have free access to this content
    The clinical analgesic efficacy of buprenorphine

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 6, December 2014, Pages: 577–583, R. B. Raffa, M. Haidery, H.-M. Huang, K. Kalladeen, D. E. Lockstein, H. Ono, M. J. Shope, O. A. Sowunmi, J. K. Tran and J. V. Pergolizzi Jr

    Version of Record online : 29 JUL 2014, DOI: 10.1111/jcpt.12196

  13. Arrhythmia associated with buprenorphine and methadone reported to the food and drug administration

    Addiction

    Volume 110, Issue 9, September 2015, Pages: 1468–1475, David P. Kao, Mark C. P. Haigney, Philip S. Mehler and Mori J. Krantz

    Version of Record online : 29 JUL 2015, DOI: 10.1111/add.13013

  14. The history of the development of buprenorphine as an addiction therapeutic

    Annals of the New York Academy of Sciences

    Volume 1248, Issue 1, February 2012, Pages: 124–139, Nancy D. Campbell and Anne M. Lovell

    Version of Record online : 18 JAN 2012, DOI: 10.1111/j.1749-6632.2011.06352.x

  15. Conversion from High-Dose Full-Opioid Agonists to Sublingual Buprenorphine Reduces Pain Scores and Improves Quality of Life for Chronic Pain Patients

    Pain Medicine

    Volume 15, Issue 12, December 2014, Pages: 2087–2094, Danielle Daitch, Jonathan Daitch, Daniel Novinson, Michael Frey, Carol Mitnick and Joseph Pergolizzi Jr

    Version of Record online : 12 SEP 2014, DOI: 10.1111/pme.12520

  16. The novel depot of buprenorphine propionate has a long-acting effect on physical dependence on morphine

    Drug Development Research

    Volume 67, Issue 5, May 2006, Pages: 462–469, Kuo-Sheng Liu, Ching-Nan Lin, Ja-Ping Shieh, Chin-Chen Chu, Chun-Hsiung Kuei and Jhi-Joung Wang

    Version of Record online : 19 SEP 2006, DOI: 10.1002/ddr.20107

  17. “Sub is a weird drug:” A web-based study of lay attitudes about use of buprenorphine to self-treat opioid withdrawal symptoms

    The American Journal on Addictions

    Volume 24, Issue 5, August 2015, Pages: 403–409, Raminta Daniulaityte, Robert Carlson, Gregory Brigham, Delroy Cameron and Amit Sheth

    Version of Record online : 25 MAY 2015, DOI: 10.1111/ajad.12213

  18. Opioid-related mortality and filled prescriptions for buprenorphine and methadone

    Drug and Alcohol Review

    Volume 33, Issue 5, September 2014, Pages: 491–498, Birgitta N. Wikner, Inger Öhman, Tor Seldén, Henrik Druid, Lena Brandt and Helle Kieler

    Version of Record online : 16 APR 2014, DOI: 10.1111/dar.12143

  19. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia

    Addiction

    Volume 110, Issue 4, April 2015, Pages: 646–655, Lucy Burns, Natasa Gisev, Sarah Larney, Timothy Dobbins, Amy Gibson, Jo Kimber, Briony Larance, Richard P. Mattick, Tony Butler and Louisa Degenhardt

    Version of Record online : 15 MAR 2015, DOI: 10.1111/add.12834

  20. Basic pharmacology of buprenorphine

    European Journal of Pain Supplements

    Volume 1, Issue S1, September 2007, Pages: 69–73, Michiteru Ohtani

    Version of Record online : 6 JAN 2012, DOI: 10.1016/S1754-3207(08)60017-6